0       0

2015 ISHLT Annual Meeting and Scientific Sessions


CCS40c - CONCURRENT SESSION 40: Lung AMR: HLA and Beyond -- The Deleterious Effect of De Novo DQ Donor Specific Antibody in Lung Transplant Is Not Related to the MFI Values of Luminex Single Antigen Assay


Apr 17, 2015 5:00pm ‐ Apr 17, 2015 5:15pm

Description

Presentation Includes
 

  • HLA Matching at the Epitope Level Protects Against Chronic Lung Allograft Dysfunction
  • A Three Center Study Reveals New Insights into the Impact of Non-HLA Antibodies on the Acute Rejection Process in Lung Transplantation
  • The Deleterious Effect of De Novo DQ Donor Specific Antibody in Lung Transplant Is Not Related to the MFI Values of Luminex Single Antigen Assay
  • New Insights in to the Impact of Auto-Antibodies on the Acute Rejection Process in Lung Transplantation
  • Donor-Specific HLA Antibodies After Lung Transplantation: Extended Follow-Up From the HALT Study
  • Human Intravenous Immunoglobulins With Rituximab vs. Therapeutic Plasma Exchange With Rituximab for Pre-Emptive Treatment of Early Donors Specific Antibodies After Lung Transplantation: Preliminary Result

Speaker(s):

  • Aiwen Zhang, PhD, Cleveland Clinic, Cleveland, OH, United States

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content